Continuous Renal Replacement Therapy Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Continuous Renal Replacement Therapy Market Analysis
The Continuous Renal Replacement Therapy Market is expected to register a CAGR of 7.2% during the forecast period. Continuous renal replacement therapy (CRRT) is commonly used in critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable to provide renal support.
Acute kidney injury (AKI) is a sudden episode of kidney damage or kidney failure that happens within a few hours or a few days. Acute kidney injury (AKI) results in build-up of waste products in blood and makes it hard for kidneys to keep the right balance of fluid in the body. Acute kidney injury (AKI) can also affect other organs such as the brain, heart, and lungs. Acute kidney injury generally common in patients who are in the hospital, in intensive care units, and especially in older adults. According to the International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury (AKI) globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. Increasing geriatric population and incidences of acute kidney injury, technological advancements in continuous renal replacement therapy are the key driving factors in continuous renal replacement therapy market.
Continuous Renal Replacement Therapy Market Trends
This section covers the major market trends shaping the Continuous Renal Replacement Therapy Market according to our research experts:
Continuous Venovenous Haemofiltration Segment is Expected to Hold a Major Market Share in the Continuous Renal Replacement Therapy Market
- Continuous Veno-Venous Hemofiltration (CVVH) is a temporary treatment for patients suffering with acute renal failure who are unable to tolerate hemodialysis and are unstable. With Continuous Veno-Venous Hemofiltration (CVVH), a dialysis catheter is placed in one of the main veins of the body.
- According to International Society of Nephrology, Acute kidney injury (AKI) is experienced by 13.3 million patients every year globally and between 5.3 and 10.5 million people require dialysis or transplantation.
- Continuous venovenous haemofiltration segment hold a significant market share in the continuous renal replacement therapy market and is anticipated to show similar trend over the forecast period due to high acceptance of continuous venovenous haemofiltration by nephrologists, because it is more feasible than the other modes and also incurs less complications than other modes of continuous renal replacement therapy.
- Increasing geriatric population and incidences of acute kidney injury and technological advancements are the key driving factors in the continuous venovenous haemofiltration segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global continuous renal replacement therapy market due to rise in geriatric population and increasing incidences of acute kidney injury in this region. According to Centers for Disease Control and Prevention (CDC), approximately 30 million people or 15% of United States adults are estimated to have chronic kidney disease (CKD). chronic kidney disease (CKD) is estimated to be more common in women (16%) than in men (13%). Furthermore, high adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.
Continuous Renal Replacement Therapy Industry Overview
The Continuous Renal Replacement Therapy Market is moderately fragmented competitive and consists of several major players. In terms of market share, few of the major manufacturersare currently dominating the capital equipment segment of the market. Some of the companies which are currently dominating the market are Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG, Baxter International, Inc, Fresenius Medical Care AG & Co. KgaA, Infomed SA, Medica SpA, Medical Components, Inc, Medites Pharma Spol. S.R.O, Medtronic PLC, and Toray Medical Co., Ltd.
Continuous Renal Replacement Therapy Market Leaders
Asahi Kasei Medical Co., Ltd
B. Braun Melsungen AG
Baxter International, Inc
Fresenius Medical Care AG & Co. KgaA
Infomed SA
*Disclaimer: Major Players sorted in no particular order
Continuous Renal Replacement Therapy Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rise in Aging Population Increases Incidences of Acute Kidney Injury
-
4.2.2 Technological Advancements in Continuous Renal Replacement Therapy
-
-
4.3 Market Restraints
-
4.3.1 Stringent Regulatory Issues
-
4.3.2 High Cost Associated Continuous Renal Replacement Therapy
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Mode
-
5.1.1 Continuous Venovenous Hemodialysis
-
5.1.2 Continuous Venovenous Hemofiltration
-
5.1.3 Continuous Venovenous Hemodiafiltration
-
5.1.4 Slow Continuous Ultrafiltration
-
-
5.2 By Product Type
-
5.2.1 Dialysate and Replacement Fluids
-
5.2.2 Disposables
-
5.2.3 Systems
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Asahi Kasei Medical Co., Ltd
-
6.1.2 B. Braun Melsungen AG
-
6.1.3 Baxter International, Inc.
-
6.1.4 Fresenius Medical Care AG & Co. KgaA
-
6.1.5 Infomed SA
-
6.1.6 Medica SpA
-
6.1.7 Medical Components, Inc
-
6.1.8 Medites Pharma Spol. S.R.O
-
6.1.9 Medtronic PLC
-
6.1.10 Toray Medical Co., Ltd
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Continuous Renal Replacement Therapy Industry Segmentation
Continuous Renal Replacement Therapy (CRRT) is commonly used in critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable to provide renal support. Continuous Renal Replacement Therapy Market are segmented by Mode, By Product Type and Geography.
| By Mode | |
| Continuous Venovenous Hemodialysis | |
| Continuous Venovenous Hemofiltration | |
| Continuous Venovenous Hemodiafiltration | |
| Slow Continuous Ultrafiltration |
| By Product Type | |
| Dialysate and Replacement Fluids | |
| Disposables | |
| Systems |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Continuous Renal Replacement Therapy Market Research FAQs
What is the current Continuous Renal Replacement Therapy Market size?
The Continuous Renal Replacement Therapy Market is projected to register a CAGR of 7.20% during the forecast period (2024-2029)
Who are the key players in Continuous Renal Replacement Therapy Market?
Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG, Baxter International, Inc, Fresenius Medical Care AG & Co. KgaA and Infomed SA are the major companies operating in the Continuous Renal Replacement Therapy Market.
Which is the fastest growing region in Continuous Renal Replacement Therapy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Continuous Renal Replacement Therapy Market?
In 2024, the North America accounts for the largest market share in Continuous Renal Replacement Therapy Market.
What years does this Continuous Renal Replacement Therapy Market cover?
The report covers the Continuous Renal Replacement Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Continuous Renal Replacement Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Continuous Renal Replacement Therapy Industry Report
Statistics for the 2024 Continuous Renal Replacement Therapy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Continuous Renal Replacement Therapy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
